(Q35784172)

10 August 2017

title

Clinicopathological significance of FHIT protein expression in gastric adenocarcinoma patients (English)

1 reference

10 August 2017

1 reference

gastric adenocarcinoma

1 reference

Po Zhao

1

1 reference

10 August 2017

Wu Liu

series ordinal

2

1 reference

10 August 2017

Ya-Li Lu

series ordinal

3

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 September 2005

1 reference

World Journal of Gastroenterology

10 August 2017

published in

1 reference

10 August 2017

volume

11

1 reference

10 August 2017

issue

36

1 reference

10 August 2017

page(s)

5735-5738

1 reference

Restored expression of fragile histidine triad protein and tumorigenicity of cervical carcinoma cells

10 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4481500

Different gene expression of MDM2, GAGE-1, -2 and FHIT in hepatocellular carcinoma and focal nodular hyperplasia

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4481500

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4481500

The role of deletions at the FRA3B/FHIT locus in carcinogenesis.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4481500

Absence or reduction of Fhit expression in most clear cell renal carcinomas.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4481500

Genetic, biochemical, and crystallographic characterization of Fhit-substrate complexes as the active signaling form of Fhit

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4481500

Absence of Fhit protein in primary lung tumors and cell lines with FHIT gene abnormalities.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4481500

Loss of FHIT expression in cervical carcinoma cell lines and primary tumors.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4481500

FHIT gene alterations in head and neck squamous cell carcinomas

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4481500

The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4481500

Tumour suppressor gene expression correlates with gastric cancer prognosis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4481500

Loss of FHIT protein expression correlates with disease progression and poor differentiation in gastric cancer

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4481500

Loss of fragile histidine triad expression in colorectal carcinoma

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4481500

Altered expression of the fragile histidine triad gene in primary gastric adenocarcinomas

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4481500

Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4481500

Anomalous transcripts and allelic deletions of the FHIT gene in human esophageal cancer.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4481500

Abnormal Fhit expression in malignant and premalignant lesions of the cervix.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4481500

Nonrandom breakpoints of unbalanced chromosome translocations in human hepatocellular carcinoma cell lines

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4481500

Loss of FHIT expression in gastric carcinoma.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4481500

Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4481500

Aberrant FHIT transcripts in hepatocellular carcinomas

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4481500

FHIT gene alterations in esophageal cancer and ulcerative colitis (UC).

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4481500

FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4481500

Aberrant fragile histidine triad gene transcripts in primary hepatocellular carcinoma and liver cirrhosis

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4481500

The FHIT gene at 3p14.2 is abnormal in breast carcinomas

25 September 2018

1 reference

12 December 2020

Loss of FHIT function in lung cancer and preinvasive bronchial lesions

1 reference

12 December 2020

The FHIT gene is expressed in pancreatic ductular cells and is altered in pancreatic cancers

1 reference

12 December 2020

Frequent deletions of FHIT and FRA3B in Barrett's metaplasia and esophageal adenocarcinomas

1 reference

12 December 2020

Role of FHIT in human cancer

1 reference

12 December 2020

Loss of fragile histidine triad expression in colorectal carcinomas and premalignant lesions

1 reference

12 December 2020

Analysis of the fragile histidine triad gene in primary gastric carcinomas and gastric carcinoma cell lines

1 reference

12 December 2020

Aberrant FHIT transcripts in squamous cell carcinoma of the uterine cervix

1 reference

12 December 2020

FHIT loss of function in human primary breast cancer correlates with advanced stage of the disease

1 reference

12 December 2020

Fhit expression in gastric adenocarcinoma: correlation with disease stage and survival

1 reference

12 December 2020

Alterations of the FHIT gene in human hepatocellular carcinoma.

1 reference

12 December 2020

Study of FHIT transcripts in normal and malignant breast tissue

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V11.I36.5735

1 reference

10 August 2017

1 reference

10 August 2017

1 reference